By admin 
CureSearch for Children’s Cancer, a national non-profit organization dedicated to ending childhood cancer by driving targeted and innovative research, has officially announced the appointment of Mark Zafra to its Board of Directors. Zafra, a high-ranking executive with extensive experience in global supply chain management and procurement, joins the board at a critical juncture for the organization as it seeks to bridge the gap between laboratory discoveries and clinical applications. Currently serving as the Chief Procurement Officer at LiveRamp, Zafra brings more than twenty years of leadership experience to the role, having spearheaded major operational transformations at some of the world’s most prominent technology and healthcare companies. His appointment is seen as a strategic move to integrate corporate operational excellence with the philanthropic mission of advancing pediatric oncology.
The addition of Zafra to the leadership team is characterized not only by his professional pedigree but also by his personal history as a cancer survivor. This dual perspective is expected to provide CureSearch with a unique vantage point, combining the rigors of corporate efficiency with a firsthand understanding of the patient experience. As the organization continues to navigate the complexities of funding high-risk, high-reward research, Zafra’s expertise in strategic sourcing and global purchasing is anticipated to enhance the stewardship of donor resources and the efficacy of the organization’s grant-making processes.
A Legacy of Operational Leadership and Strategic Sourcing
Mark Zafra’s professional trajectory is defined by a consistent record of driving innovation within large-scale, complex organizations. At LiveRamp, a leading data collaboration platform, Zafra oversees a comprehensive portfolio that includes global strategic sourcing, purchasing, corporate travel, and accounts payable. His role is central to the company’s operational stability and growth, requiring a meticulous approach to resource allocation and vendor management.
Before his tenure at LiveRamp, Zafra held senior leadership positions at several industry titans. At Twitter, he was instrumental in scaling procurement operations during periods of rapid international expansion. His career also includes significant contributions to Allianz Fireman’s Fund, McKesson, HP, and Agilent Technologies. These roles required a deep understanding of how supply chains function within the healthcare and technology sectors—knowledge that is directly transferable to the logistical challenges of medical research and drug development.
In the context of a non-profit like CureSearch, procurement and supply chain expertise are increasingly vital. The process of bringing a new pediatric cancer drug to market involves a complex "supply chain" of its own, stretching from academic research and intellectual property management to clinical trial logistics and regulatory compliance. Zafra’s ability to streamline these processes and identify efficiencies is expected to help CureSearch maximize the impact of every dollar raised.
The Intersection of Personal Advocacy and Philanthropy
While Zafra’s professional resume is distinguished, his personal connection to the cause of cancer research serves as the cornerstone of his commitment to CureSearch. As a cancer survivor, Zafra has navigated the physical and emotional toll of a diagnosis, a journey that began 20 years ago. This milestone year serves as the backdrop for his increased involvement with the organization.
In addition to his board service, Zafra is a participant in the CureSearch Ultimate Hike. This endurance event, held in Jackson, Wyoming, challenges participants to complete a rigorous trek to raise funds for childhood cancer research. For Zafra, the hike is a symbolic representation of the 20 years that have passed since his first diagnosis and a tangible way to contribute to the future of pediatric care. The Ultimate Hike program is one of CureSearch’s flagship fundraising initiatives, emphasizing the "uphill battle" faced by children with cancer and the resilience required to overcome the disease.
"It is with great enthusiasm and a deep sense of responsibility that I join CureSearch’s Board of Directors," Zafra stated regarding his appointment. "As a survivor myself, I am a passionate advocate for advancing cancer research and am honored by the opportunity to contribute my skills and experience to a mission that matters deeply to me."
The Landscape of Pediatric Cancer Research and Funding Gaps
The appointment of a procurement expert like Zafra highlights the growing need for strategic resource management in the field of pediatric oncology. Despite significant advancements in adult cancer treatments, pediatric cancer research remains historically underfunded and underserved by the traditional pharmaceutical industry.
According to data from the National Cancer Institute (NCI), only about 4% of federal funding for cancer research is specifically allocated to childhood cancers. This disparity creates a "funding gap" that non-profit organizations like CureSearch must fill. Furthermore, because childhood cancers are biologically distinct from adult cancers, treatments developed for adults are often ineffective or overly toxic for children, leading to long-term health complications for survivors.
CureSearch addresses these challenges by focusing on the "Valley of Death"—the stage in drug development where promising laboratory research often stalls due to a lack of funding for Phase I and Phase II clinical trials. By applying a venture-philanthropy model, CureSearch identifies the most promising research projects and provides the necessary capital and strategic guidance to move them toward commercialization and patient use. Zafra’s experience in managing large-scale transformation initiatives is expected to refine this model, ensuring that the organization’s "portfolio" of research projects is managed with the same rigor as a corporate investment fund.
Chronology of Mark Zafra’s Career and Engagement
The integration of Mark Zafra into the CureSearch leadership structure follows a timeline of professional excellence and escalating philanthropic engagement:
- Early 2000s: Zafra establishes a foundation in procurement and supply chain management at HP and Agilent Technologies, focusing on operational efficiency in the tech sector.
- 2004: Zafra receives his first cancer diagnosis, a pivotal event that would eventually steer his professional skills toward advocacy.
- 2010s: Zafra takes on leadership roles at McKesson and Allianz Fireman’s Fund, gaining insights into the intersection of finance, insurance, and healthcare logistics.
- 2018–2022: During his tenure at Twitter, Zafra manages global strategic sourcing, honing his ability to lead transformation in high-growth, high-pressure environments.
- 2023: Zafra joins LiveRamp as Chief Procurement Officer, overseeing a global team and multi-million dollar budgets.
- 2024: Zafra is appointed to the CureSearch Board of Directors and commits to the Jackson, WY, Ultimate Hike, marking 20 years of cancer survivorship.
Official Responses and Strategic Vision
The leadership at CureSearch has expressed high confidence in Zafra’s ability to contribute to the organization’s long-term goals. Jared Brancazio, the CureSearch Board Chair, emphasized the importance of Zafra’s diverse skill set in a statement welcoming him to the board.
"Mark’s professional leadership and personal commitment to advancing cancer research make him an incredible addition to the CureSearch Board," said Brancazio. "We’re honored to have him help guide our work and accelerate our impact. His background in procurement and supply chain management provides a fresh perspective on how we can optimize our operations and deliver results for the children and families we serve."
The strategic vision for CureSearch involves expanding its reach into international research collaborations and increasing the pace of clinical trial enrollment. The organization currently supports a wide array of research initiatives, including the Catapult Awards, which provide significant funding to bring new treatments to the clinic. Zafra’s role will involve reviewing the operational frameworks of these programs to ensure they are scalable and sustainable.
Broader Implications for Non-Profit Governance
The appointment of Mark Zafra reflects a broader trend in the non-profit sector: the recruitment of C-suite executives from the technology and finance sectors to board positions. As non-profits face increasing pressure to demonstrate measurable impact and fiscal transparency, the "corporate-non-profit synergy" has become a vital component of successful governance.
For CureSearch, Zafra’s expertise in accounts payable and global strategic sourcing translates to better risk management and more robust financial oversight. In an era where donors are increasingly looking for "ROI" (Return on Impact), having a Chief Procurement Officer on the board signals a commitment to operational lean-ness and strategic growth.
Furthermore, the focus on supply chain management is particularly relevant in the post-pandemic era, where the global medical supply chain has faced unprecedented disruptions. Ensuring that research laboratories and clinical trial sites have the necessary resources to continue their work without interruption is a logistical challenge that Zafra is uniquely qualified to address.
Future Outlook: Accelerating the Path to a Cure
As Mark Zafra begins his tenure on the Board of Directors, the immediate focus will be on supporting CureSearch’s upcoming research cycles and fundraising events. The 2024 Jackson, WY, Ultimate Hike will serve as a high-visibility platform for Zafra to advocate for the cause and engage with the broader CureSearch community.
Looking ahead, the organization aims to leverage Zafra’s network and expertise to forge new partnerships with biotechnology firms and data analytics companies. By integrating data-driven procurement strategies with cutting-edge oncological research, CureSearch hopes to reduce the time it takes for a new drug to move from the bench to the bedside.
The ultimate goal remains clear: ensuring that every child diagnosed with cancer has access to safe and effective treatment options. With the addition of Mark Zafra, CureSearch for Children’s Cancer reinforces its position as a leader in the field, combining the heart of a survivor with the mind of a seasoned executive to change the trajectory of childhood cancer forever.
